Machine signal
Active cluster buy — 5 distinct insiders, $158K, window ends Aug 26, 2026.
Figures computed from official regulatory filings — .
Analysttarget 13 USD (+534%)
Ownershipinsiders 17.97% · institutions 2.72% · short 0.9% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for BIOMERICA INC only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe, the Middle East, and South America. The company offers diagnostic test kits are used to analyze blood, urine, nasal, or fecal material from patients to aid in the diagnosis of diseases, food intolerances, and other medical conditions, as well as detect and measure the presence and levels of specific bacteria, hormones, antibodies, antigens, and other substances that may exist in the human body at extremely low concentrations through clinical laboratories and in point-of-care settings, including physicians' offices and over-the-counter channels. It also provides contract development and manufacturing services to third parties. In addition, the company commercializes inFoods IBS product through physician-directed and laboratory-based channels, such as third-party reimbursement pathways. Further, it is involved in the development and optimization of immunoassays, enzyme-linked immunosorbent assays, rapid diagnostic tests, and related diagnostic technologies; and research, development, commercialization of diagnostic-guided therapy (DGT) products to treat gastrointestinal diseases, such as irritable bowel syndrome (IBS), and other inflammatory diseases. Additionally, the company offers EZ detect colon disease home test; Aware Breast Self-Exam product; and hp+detect, a diagnostic test designed to detect Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
101 buys22 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| IRANI ZACHARYStrack record | Buy | $50K | conv 82 |
| SEC |
| MOATAZEDI DAVID | Buy | $16K | conv 75ClusterFirst in 12mo | SEC |
| Chin Eric | Buy | $10K | conv 72ClusterFirst in 12mo | SEC |
| Gary M. Huff | Buy | $50K | conv 88First in 12mo | SEC |
| BARBIERI ALLEN | Buy | $32K | conv 84ClusterUnusual size+1 | SEC |
| Chin Eric | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| BARBIERI ALLEN | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Gary M. Huff | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Lu Gary | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| IRANI ZACHARYStrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MOATAZEDI DAVID | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Coste Catherine | Award | $26.4K | SEC |
| Emerson Jane | Award | $26.4K | SEC |
| IRANI ZACHARYStrack record | Award | $77.5K | Unusual size | SEC |
| Lu Gary | Award | $48.1K | SEC |
| MOATAZEDI DAVID | Award | $26.4K | Unusual size | SEC |
| BARBIERI ALLEN | Award | $34.1K | Unusual size | SEC |
| BARBIERI ALLEN | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| BARBIERI ALLEN | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Coste Catherine | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| MOATAZEDI DAVID | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Emerson Jane | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Kenny John P.track record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| IRANI ZACHARYStrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| BARBIERI ALLEN | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |